DK1696922T3 - Anvendelse af et hydroximinsyre-halogenid-derivat til behandling af neurodegenerative sygdomme - Google Patents
Anvendelse af et hydroximinsyre-halogenid-derivat til behandling af neurodegenerative sygdommeInfo
- Publication number
- DK1696922T3 DK1696922T3 DK04791657T DK04791657T DK1696922T3 DK 1696922 T3 DK1696922 T3 DK 1696922T3 DK 04791657 T DK04791657 T DK 04791657T DK 04791657 T DK04791657 T DK 04791657T DK 1696922 T3 DK1696922 T3 DK 1696922T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- neurodegenerative diseases
- acid halide
- halide derivative
- hydroxymic acid
- Prior art date
Links
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000004820 halides Chemical class 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- SGEIEGAXKLMUIZ-PEZBUJJGSA-N (3z)-n-(2-hydroxy-3-piperidin-1-ylpropoxy)-1-oxidopyridin-1-ium-3-carboximidoyl chloride Chemical compound C1CCCCN1CC(O)CO\N=C(/Cl)C1=CC=C[N+]([O-])=C1 SGEIEGAXKLMUIZ-PEZBUJJGSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0303584A HUP0303584A3 (en) | 2003-10-30 | 2003-10-30 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| PCT/HU2004/000098 WO2005041965A1 (en) | 2003-10-30 | 2004-10-25 | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1696922T3 true DK1696922T3 (da) | 2008-12-01 |
Family
ID=89981738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04791657T DK1696922T3 (da) | 2003-10-30 | 2004-10-25 | Anvendelse af et hydroximinsyre-halogenid-derivat til behandling af neurodegenerative sygdomme |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US20080039497A1 (ru) |
| EP (2) | EP2020233A3 (ru) |
| JP (1) | JP5077997B2 (ru) |
| KR (1) | KR20060103323A (ru) |
| CN (1) | CN1901913A (ru) |
| AT (1) | ATE409038T1 (ru) |
| AU (1) | AU2004285343B2 (ru) |
| BR (1) | BRPI0415625A (ru) |
| CA (1) | CA2544332C (ru) |
| CY (1) | CY1110450T1 (ru) |
| CZ (1) | CZ2006347A3 (ru) |
| DE (1) | DE602004016770D1 (ru) |
| DK (1) | DK1696922T3 (ru) |
| EA (1) | EA011301B1 (ru) |
| ES (1) | ES2314458T3 (ru) |
| HK (1) | HK1097438A1 (ru) |
| HR (1) | HRP20080660T3 (ru) |
| HU (1) | HUP0303584A3 (ru) |
| IL (1) | IL175334A (ru) |
| NO (1) | NO20062401L (ru) |
| NZ (1) | NZ547216A (ru) |
| PL (1) | PL1696922T3 (ru) |
| PT (1) | PT1696922E (ru) |
| SI (1) | SI1696922T1 (ru) |
| UA (1) | UA86782C2 (ru) |
| WO (1) | WO2005041965A1 (ru) |
| ZA (1) | ZA200604376B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057664A1 (en) | 2002-01-11 | 2003-07-17 | Biorex Kutató És Fejlesztö Rt. | Carboxamidine derivatives and their use in the treatment of vascular diseases |
| TW200831479A (en) * | 2006-09-26 | 2008-08-01 | Cytrx Corp | Pharmaceutical compositions and methods for treating diseases |
| HUE025852T2 (en) | 2008-06-26 | 2016-04-28 | Orphazyme Aps | Use of HSP70 to regulate enzyme activity |
| KR20110084514A (ko) | 2008-11-18 | 2011-07-25 | 산텐 세이야꾸 가부시키가이샤 | 피리딘-3-카르발데히드 ｏ-(피페리딘-1-일-프로필)-옥심 유도체를 유효 성분으로서 함유하는 망맥락막 변성 질환의 치료제 |
| RU2013125923A (ru) | 2010-11-30 | 2015-01-10 | Орфазиме Апс | СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70 |
| HUP1100534A2 (en) * | 2011-09-26 | 2013-04-29 | Balazs Dr Hazay | Pharmaceutical composition for the treatment of muscle atrophy |
| CN103804309B (zh) * | 2012-11-09 | 2019-08-02 | 广州喜鹊医药有限公司 | 一种氯肟类化合物及其制备方法和在制药中的应用 |
| PL3193840T3 (pl) * | 2014-09-15 | 2021-12-06 | Orphazyme A/S | Preparat arimoklomolu |
| EP3442530A1 (en) | 2016-04-13 | 2019-02-20 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
| RS61291B1 (sr) * | 2016-04-29 | 2021-02-26 | Orphazyme As | Arimoklomol za lečenje poremećaja povezanih sa glukocerebrozidazom |
| CN110753544A (zh) | 2017-05-24 | 2020-02-04 | 奥菲泽米有限公司 | 热激蛋白诱导物和额颞病况 |
| HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
| MX2023005954A (es) | 2020-11-19 | 2023-09-04 | Zevra Denmark As | Procesos para preparar citrato de arimoclomol e intermediarios del mismo. |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU177578B (en) | 1976-08-27 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives |
| DE2651083A1 (de) * | 1976-11-09 | 1978-05-18 | Hoechst Ag | Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| HUT54347A (en) | 1989-01-10 | 1991-02-28 | Chinoin Gyogyszer Es Vegyeszet | Improved process for producing amidoximes |
| US5334600A (en) * | 1991-07-30 | 1994-08-02 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
| WO1995030649A1 (en) | 1994-05-06 | 1995-11-16 | Biorex Kutató És Fejleszto^' Rt. | Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same |
| HU9502843D0 (en) * | 1995-09-29 | 1995-11-28 | Livigene Ltd | Pharmaceutical composition |
| HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
| UA64716C2 (en) | 1996-08-09 | 2004-03-15 | Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells | |
| HU220971B1 (hu) | 1997-04-03 | 2002-07-29 | BIOREX Kutató és Fejlesztő Rt. | Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására |
| UA65635C2 (ru) * | 1998-09-03 | 2004-04-15 | Н-Гене Кутато Кфт. | НЕНАСЫЧЕННЫЕ ПРОИЗВОДНЫЕ ГИДРОКСИМОВОЙ КИСЛОТЫ, ИМЕЮЩИЕ СВОЙСТВА ИНГИБИТОРОВ NAD<sup>+-ADP-РИБОЗИЛТРАНСФЕРАЗЫ |
| HUP9900475D0 (en) * | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
| HUP0001583A2 (hu) | 2000-04-18 | 2002-11-28 | BIOREX Kutató és Fejlesztő Rt. | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké |
| HU0103939D0 (en) | 2001-09-27 | 2001-11-28 | Biorex Kutato Fejlesztoe Kft | Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride |
| ITMI20012573A1 (it) | 2001-12-06 | 2003-06-06 | D B P Dev Biotechonologica L P | Gli acilsalicilati:una nuova classe di induttori di risposta heat shock |
-
2003
- 2003-10-30 HU HU0303584A patent/HUP0303584A3/hu unknown
-
2004
- 2004-10-25 US US10/582,124 patent/US20080039497A1/en not_active Abandoned
- 2004-10-25 CZ CZ20060347A patent/CZ2006347A3/cs unknown
- 2004-10-25 UA UAA200605899A patent/UA86782C2/ru unknown
- 2004-10-25 CN CNA2004800396198A patent/CN1901913A/zh active Pending
- 2004-10-25 ES ES04791657T patent/ES2314458T3/es not_active Expired - Lifetime
- 2004-10-25 DK DK04791657T patent/DK1696922T3/da active
- 2004-10-25 PT PT04791657T patent/PT1696922E/pt unknown
- 2004-10-25 JP JP2006537449A patent/JP5077997B2/ja not_active Expired - Fee Related
- 2004-10-25 ZA ZA200604376A patent/ZA200604376B/xx unknown
- 2004-10-25 BR BRPI0415625-0A patent/BRPI0415625A/pt not_active Application Discontinuation
- 2004-10-25 AU AU2004285343A patent/AU2004285343B2/en not_active Ceased
- 2004-10-25 EA EA200600866A patent/EA011301B1/ru not_active IP Right Cessation
- 2004-10-25 NZ NZ547216A patent/NZ547216A/en unknown
- 2004-10-25 EP EP08157425A patent/EP2020233A3/en not_active Withdrawn
- 2004-10-25 SI SI200430887T patent/SI1696922T1/sl unknown
- 2004-10-25 AT AT04791657T patent/ATE409038T1/de active
- 2004-10-25 WO PCT/HU2004/000098 patent/WO2005041965A1/en active IP Right Grant
- 2004-10-25 KR KR1020067010489A patent/KR20060103323A/ko not_active Application Discontinuation
- 2004-10-25 PL PL04791657T patent/PL1696922T3/pl unknown
- 2004-10-25 DE DE602004016770T patent/DE602004016770D1/de not_active Expired - Lifetime
- 2004-10-25 CA CA2544332A patent/CA2544332C/en not_active Expired - Fee Related
- 2004-10-25 EP EP04791657A patent/EP1696922B1/en not_active Expired - Lifetime
-
2006
- 2006-04-30 IL IL175334A patent/IL175334A/en not_active IP Right Cessation
- 2006-05-26 NO NO20062401A patent/NO20062401L/no not_active Application Discontinuation
-
2007
- 2007-03-06 HK HK07102495.9A patent/HK1097438A1/xx not_active IP Right Cessation
-
2008
- 2008-12-10 CY CY20081101426T patent/CY1110450T1/el unknown
- 2008-12-19 HR HR20080660T patent/HRP20080660T3/xx unknown
-
2011
- 2011-09-12 US US13/229,862 patent/US8962604B2/en not_active Expired - Fee Related
-
2015
- 2015-01-12 US US14/594,817 patent/US20150126551A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL175334A0 (en) | Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases | |
| ATE484494T1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| NO20093464L (no) | Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika | |
| BRPI0519567A2 (pt) | heterociclos tricÍclicos, sua fabricaÇço e uso como agentes farmacÊuticos | |
| DE60132309D1 (de) | Amin-derivate zur behandlung von apoptosis | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| EA200400476A1 (ru) | Производные аминоиндазола, активные в качестве ингибиторов киназ, способ их получения и содержащая их фармацевтическая композиция | |
| ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
| SE0301446D0 (sv) | New Compounds | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| SE0102440D0 (sv) | New compound | |
| NO20025015L (no) | Et pyridin-1-oksidderivat, og fremgangsmåte for dets overföring til farmasöytisk effektive forbindelser | |
| ATE444069T1 (de) | Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen | |
| SE0401655D0 (sv) | New compounds | |
| HRP20050831A2 (en) | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents | |
| BRPI0409957A (pt) | imidazolin-2-ilaminofenil amidas | |
| SE9900190D0 (sv) | New compounds | |
| BRPI0409951A (pt) | derivados de anilina, sua produção e uso como agentes farmacêuticos | |
| UA108342C2 (uk) | Спосіб одержання 4-((1r,3s)-6-хлор-3-феніліндан-1-іл)-1,2,2-триметилпіперазину або його солі (варіанти), цис-(1s,3s)-6-хлор-3-феніліндан-1-ол, цис-(1s,3s)-3-заміщений-5-хлор-1-феніліндан та транс-1-((1r,3s)-6-хлор-3-феніліндан-1-іл)-3,3-диметилпіперазин | |
| ATE321554T1 (de) | 2-methylthiazolidin-2,4-dicarbonsaeure und deren salze zur behandlung von neurodegenerativen erkrankungen |